GE HealthCare Technologies Inc.
GEHC
주식 순위
#777
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
주가
$68.98
시가총액
$31.16B
변동 (1일)
-1.78%
변동 (1년)
-9.35%
국가
US
거래 GE HealthCare Technologies Inc. (GEHC)
카테고리
Healthcare
GE HealthCare Technologies Inc. (GEHC)의 매출
Jun 2026 기준 매출 TTM: $20.24B
GE HealthCare Technologies Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $20.24B입니다. 2024년에 회사는 $19.67B의 수익을 올렸으며 이는 2023년의 $19.55B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
GE HealthCare Technologies Inc.의 수익 기록 (2019 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $20.24B | -1.85% |
| 2025 | $20.63B | 4.84% |
| 2024 | $19.67B | 0.61% |
| 2023 | $19.55B | 6.60% |
| 2022 | $18.34B | 4.30% |
| 2021 | $17.59B | 2.45% |
| 2020 | $17.16B | 3.19% |
| 2019 | $16.63B | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $184.56M | -99.09% |
AU
|
|
| $14.37B | -29.00% |
US
|
|
| $1.43B | -92.93% |
US
|
|
| $616.91M | -96.95% |
US
|
|
| - | - |
US
|
